QuickLinks -- Click here to rapidly navigate through this document

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

        We consent to the reference to our firm under the caption "Experts" and to the use of our report dated March 17, 2014, in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-194621) and related Prospectus of Agile Therapeutics, Inc. dated April 17, 2014 for the registration of 000,000 shares of its common stock.

/s/ Ernst & Young LLP

Metropark, New Jersey
April 17, 2014

QuickLinks

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm